BRUSSELS (Sputnik) – The European Medicines Agency (EMA) told Sputnik that it completed scientific consultations with Russia’s Gamaleya research centre that developed the Sputnik V coronavirus vaccine, which means that Moscow can now submit an application for vaccine authorization for the EU market.